Literature DB >> 18952508

Searching biomarker candidates in serum using multidimensional native chromatography. II Method evaluation with Alport syndrome and severe inflammation.

Adrienne Baum1, Michael Pohl, Stefan Kreusch, Gerhard A Cumme, Günter Ditze, Joachim Misselwitz, Michael Kiehntopf, Lene Udby, Andreas Meier-Hellmann, Heidrun Rhode.   

Abstract

Biomarker search using multidimensional native liquid fractionation of serum in microplates was evaluated. From different donors, homologous sample fractions with UV absorbance depending on state of illness were selected, and their constituents were identified and quantitated by MS. Analysis of sera of patients with Alport syndrome and severe inflammation proved the reliability of the method by confirming characteristic alterations. Moreover, 23 new marker candidates were detected for Alport syndrome, some of them being involved in matrix degradation and repair, and 33 new candidates for severe inflammation, among them alpha1B-glycoprotein cysteine-rich secretory protein and an apparently low molecular-weight albumin variant.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18952508     DOI: 10.1016/j.jchromb.2008.10.014

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

Review 1.  Alport syndrome--insights from basic and clinical research.

Authors:  Jenny Kruegel; Diana Rubel; Oliver Gross
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

2.  Diagnosis of Alport syndrome--search for proteomic biomarkers in body fluids.

Authors:  Michael Pohl; Karin Danz; Oliver Gross; Ulrike John; Johannes Urban; Ludwig Patzer; Sandra Habbig; Markus Feldkötter; Oliver Witzke; Mario Walther; Heidrun Rhode
Journal:  Pediatr Nephrol       Date:  2013-06-23       Impact factor: 3.714

3.  Longitudinal study of circulating protein biomarkers in inflammatory bowel disease.

Authors:  Emilie Viennois; Mark T Baker; Bo Xiao; Lixin Wang; Hamed Laroui; Didier Merlin
Journal:  J Proteomics       Date:  2014-09-16       Impact factor: 4.044

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.